Changeflow GovPing Pharma & Drug Safety ZONNIC Nicotine Replacement Therapy Trademark A...
Routine Notice Added Draft

ZONNIC Nicotine Replacement Therapy Trademark Application

Favicon for changeflow.com ChangeBridge: Trademarks - Pharmaceuticals (Class 005)
Published January 3rd, 2025
Detected April 1st, 2026
Email

Summary

The USPTO received trademark application TM98935361 for ZONNIC covering pharmaceutical preparations for nicotine replacement therapy and smoking cessation products. The application was filed on January 3, 2025, under Intent to Use provisions, covering goods including tablets, lozenges, patches, gums, sprays, and pouches containing nicotine for medical purposes.

What changed

The USPTO published trademark application TM98935361 for ZONNIC, covering Class 5 pharmaceutical preparations for suppressing smoking, treating nicotine addiction, and nicotine replacement therapy products. The goods include medicated tablets, lozenges, patches, chewing gum, mouth sprays, and pouches. The application was filed as Intent to Use, indicating the applicant plans to use the mark in commerce but has not yet done so.

Pharmaceutical companies and drug manufacturers offering smoking cessation products should review this application for potential conflicts with existing marks. Trademark applicants have no immediate action required; the application will proceed through examination, publication for opposition, and either registration or abandonment. No compliance deadlines, penalties, or regulatory requirements arise from this trademark filing.

Source document (simplified)

← USPTO Trademark Applications

ZONNIC

Intent to Use TM98935361 Kind: intenttouse Mar 31, 2026

Abstract

Pharmaceutical preparations for suppressing, reducing, eliminating smoking and the urge to smoke; Pharmaceutical preparations for treating drug and alcohol abuse and addiction; Pharmaceutical preparations for treating nicotine addiction; Pharmaceutical preparations for nicotine replacement therapy; Pharmaceutical preparations in tablet, in lozenge form for suppressing, reducing, eliminating smoking and the urge to smoke; medicated preparations and substances for suppressing, reducing, eliminating smoking and the urge to smoke; Patches for medical purposes, namely nicotine patches for use as aids to stop smoking; Chewing gum for suppressing, reducing, eliminating smoking and the urge to smoke; Nicotine mouth sprays for medical purposes; Pouches, chewing gum, lozenges, tablets and patches containing nicotine to aid in smoking cessation.

Filing Date

2025-01-03

View original document →

Named provisions

Pharmaceutical preparations for suppressing smoking Nicotine replacement therapy preparations Class 5 - Pharmaceutical goods

Classification

Agency
USPTO
Published
January 3rd, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
TM98935361

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Consumer Protection Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.